CYTOR and renal cell carcinoma: For example, CYTOR sponged miRNA-103a-3p to promote malignant progression of glioma stem cells [34], modulated the expression of miR-193a-3p to confer resistance to oxaliplatin in colon cancer [14], and negatively regulated miR-205 to promote renal cell carcinoma progression [35].